Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia

References

• Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi:10.1016/j.ophtha.2016.01.006
   PubMed Web of Science ®Google Scholar
• Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9–25.e12. doi:10.1016/j.ajo.2013.08.010
   PubMed Web of Science ®Google Scholar
• Lee YY, Lo C-T, Sheu S-J, et al. What factors are associated with myopia in young adults? A survey study in Taiwan Military Conscripts. Invest Ophthalmol Vis Sci. 2013;54(2):1026–1033. doi:10.1167/iovs.12-10480
   PubMed Web of Science ®Google Scholar
• Lam CS, Lam C-H, Cheng SC-K, et al. Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades. Ophthalmic Physiol Opt. 2012;32(1):17–24. doi:10.1111/opo.2011.32.issue-1
   PubMed Web of Science ®Google Scholar
• Lim DH, Han J, Chung T-Y, et al. The high prevalence of myopia in Korean children with influence of parental refractive errors: the 2008–2012 Korean National Health and Nutrition Examination Survey. PLoS One. 2018;13(11):e0207690. doi:10.1371/journal.pone.0207690
   Web of Science ®Google Scholar
• Wu JF, Bi HS, Wang SM, et al. Refractive error, visual acuity and causes of vision loss in children in Shandong, China. The Shandong children eye study. PLoS One. 2013;8(12):e82763. doi:10.1371/journal.pone.0082763
   PubMed Web of Science ®Google Scholar
• Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res. 2005;24(1):1–38. doi:10.1016/j.preteyeres.2004.06.004
   PubMed Web of Science ®Google Scholar
• Zhao J, Pan X, Sui R, et al. Refractive error study in children: results from Shunyi District, China. Am J Ophthalmol. 2000;129(4):427–435. doi:10.1016/S0002-9394(99)00452-3
   PubMed Web of Science ®Google Scholar
• He M, Zeng J, Liu Y, et al. Refractive error and visual impairment in urban children in southern china. Invest Ophthalmol Vis Sci. 2004;45(3):793–799. doi:10.1167/iovs.03-1051
   PubMed Web of Science ®Google Scholar
• Fan DSP, Lam DSC, Lam RF, et al. Prevalence, incidence, and progression of myopia of school children in Hong Kong. Invest Ophthalmol Vis Sci. 2004;45(4):1071–1075. doi:10.1167/iovs.03-1151
   PubMed Web of Science ®Google Scholar
• You QS, Wu LJ, Duan JL, et al. Prevalence of myopia in school children in greater Beijing: the Beijing Childhood Eye Study. Acta Ophthalmol. 2014;92(5):e398–406. doi:10.1111/aos.12299
   PubMed Web of Science ®Google Scholar
• Guo K, Yang DY, Wang Y, et al. Prevalence of Myopia in schoolchildren in Ejina: the Gobi desert children eye study Myopia in the Gobi desert children eye study. Invest Ophthalmol Vis Sci. 2015;56(3):1769–1774. doi:10.1167/iovs.14-15737
   PubMed Web of Science ®Google Scholar
• Morgan IG, French AN, Ashby RS, et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 2018;62:134–149. doi:10.1016/j.preteyeres.2017.09.004
   PubMed Web of Science ®Google Scholar
• Walline JJ. Myopia control: a review. Eye & Contact Lens. 2016;42(1):3–8. doi:10.1097/ICL.0000000000000207
   PubMed Web of Science ®Google Scholar
• Fricke TR, Holden BA, Wilson DA, et al. Global cost of correcting vision impairment from uncorrected refractive error. Bull World Health Organ. 2012;90(10):728–738. doi:10.2471/BLT.00.000000
   PubMed Web of Science ®Google Scholar
• Yokoi T, Moriyama M, Hayashi K, et al. Predictive factors for comorbid psychiatric disorders and their impact on vision-related quality of life in patients with high myopia. Int Ophthalmol. 2014;34(2):171–183. doi:10.1007/s10792-013-9805-8
   PubMed Web of Science ®Google Scholar
• Rose K, Harper R, Tromans C, et al. Quality of life in myopia. Br J Ophthalmol. 2000;84(9):1031. doi:10.1136/bjo.84.9.1031
   PubMed Web of Science ®Google Scholar
• Watson PG, Young RD. Scleral structure, organisation and disease. A review. Exp Eye Res. 2004;78(3):609–623. doi:10.1016/S0014-4835(03)00212-4
   PubMed Web of Science ®Google Scholar
• Matthijs Blankesteijn W. Has the search for a marker of activated fibroblasts finally come to an end? J Mol Cell Cardiol. 2015;88:120–123. doi:10.1016/j.yjmcc.2015.10.005
   Web of Science ®Google Scholar
• Keeley FW, Morin JD, Vesely S. Characterization of collagen from normal human sclera. Exp Eye Res. 1984;39(5):533–542. doi:10.1016/0014-4835(84)90053-8
   PubMed Web of Science ®Google Scholar
• Gentle A, Liu Y, Martin JE, et al. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J Biol Chem. 2003;278(19):16587–16594. doi:10.1074/jbc.M300970200
   PubMed Web of Science ®Google Scholar
• Curtin BJ, Iwamoto T. Normal and staphylomatous sclera of high myopia. An electron microscopic study. Arch Ophthalmol. 1979;97(5):912–915. doi:10.1001/archopht.1979.01020010470017
   PubMedGoogle Scholar
• McBrien NA, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res. 2003;22(3):307–338. doi:10.1016/S1350-9462(02)00063-0
   PubMed Web of Science ®Google Scholar
• McBrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2000;41(12):3713–3719.
   PubMed Web of Science ®Google Scholar
• Harper AR, Summers JA. The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development. Exp Eye Res. 2015;133:100–111. doi:10.1016/j.exer.2014.07.015
   PubMed Web of Science ®Google Scholar
• Sherman SM, Norton TT, Casagrande VA. Myopia in the lid-sutured tree shrew (Tupaia glis). Brain Res. 1977;124(1):154–157. doi:10.1016/0006-8993(77)90872-1
   PubMed Web of Science ®Google Scholar
• Schaeffel F, Feldkaemper M. Animal models in myopia research. Clin Exp Optom. 2015;98(6):507–517. doi:10.1111/cxo.12312
   PubMed Web of Science ®Google Scholar
• Norton TT, Rada JA. Reduced extracellular matrix in mammalian sclera with induced myopia. Vision Res. 1995;35(9):1271–1281. doi:10.1016/0042-6989(94)00243-F
   PubMed Web of Science ®Google Scholar
• Siegwart JT Jr., Norton TT. The time course of changes in mRNA levels in tree shrew sclera during induced myopia and recovery. Invest Ophthalmol Vis Sci. 2002;43(7):2067–2075.
   PubMed Web of Science ®Google Scholar
• Wu H, Chen W, Zhao F, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci U S A. 2018;115(30):E7091–e7100. doi:10.1073/pnas.1721443115
   PubMed Web of Science ®Google Scholar
• Sickel W. Electrical and metabolic manifestations of receptor and higher-order neuron activity in vertebrate retina. In: Arden GB, editor. The Visual System: Neurophysiology, Biophysics, and Their Clinical Applications. Boston, MA: Springer US; 1972:101–118.
   Google Scholar
• Li S-Y, Fu ZJ, Lo ACY. Hypoxia-induced oxidative stress in ischemic retinopathy. Oxid Med Cell Longev. 2012;2012:10. doi:10.1155/2012/426769
   Web of Science ®Google Scholar
• Shih Y-F, Fitzgerald MEC, Norton TT, et al. Reduction in choroidal blood flow occurs in chicks wearing goggles that induce eye growth toward myopia. Curr Eye Res. 1993;12(3):219–227. doi:10.3109/02713689308999467
   PubMed Web of Science ®Google Scholar
• Yancey CM, Linsenmeier RA. The electroretinogram and choroidal PO2 in the cat during elevated intraocular pressure. Invest Ophthalmol Vis Sci. 1988;29(5):700–707.
   Web of Science ®Google Scholar
• Ohno-Matsui K. Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology. 2014;121(9):1798–1809. doi:10.1016/j.ophtha.2014.03.035
   PubMed Web of Science ®Google Scholar
• Moriyama M, Ohno-Matsui K, Hayashi K, et al. Topographic analyses of shape of eyes with pathologic myopia by high-resolution three-dimensional magnetic resonance imaging. Ophthalmology. 2011;118(8):1626–1637. doi:10.1016/j.ophtha.2011.01.018
   PubMed Web of Science ®Google Scholar
• Moriyama M, Ohno-Matsui K, Modegi T, et al. Quantitative analyses of high-resolution 3D MR images of highly myopic eyes to determine their shapes software to analyze 3D MR of highly myopic eye. Investigative Opthalmology & Visual Science. 2012;53(8):4510–4518. doi:10.1167/iovs.12-9426
   PubMed Web of Science ®Google Scholar
• Ohno-Matsui K, Alkabes M, Salinas C, et al. Features of posterior staphylomas analyzed in wide-field fundus images in patients with unilateral and bilateral pathologic Myopia. Retina. 2017;37(3):477–486. doi:10.1097/IAE.0000000000001327
   Web of Science ®Google Scholar
• He M, Huang W, Zheng Y, et al. Refractive error and visual impairment in school children in rural southern China. Ophthalmology. 2007;114(2):374–382. doi:10.1016/j.ophtha.2006.08.020
   PubMed Web of Science ®Google Scholar
• Murthy GV, Gupta SK, Ellwein LB, et al. Refractive error in children in an urban population in New Delhi. Invest Ophthalmol Vis Sci. 2002;43(3):623–631.
   PubMed Web of Science ®Google Scholar
• Dandona R, Dandona L, Srinivas M, et al. Refractive error in children in a rural population in India. Invest Ophthalmol Vis Sci. 2002;43(3):615–622.
   PubMed Web of Science ®Google Scholar
• Lin LL, Shih YF, Hsiao CK, et al. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore. 2004;33(1):27–33.
   PubMed Web of Science ®Google Scholar
• Yoon K-C, Mun G-H, Kim S-D, et al. Prevalence of eye diseases in South Korea: data from the Korea national health and nutrition examination survey 2008–2009. Korean J Ophthalmol. 2011;25(6):421–433. doi:10.3341/kjo.2011.25.6.421
   PubMedGoogle Scholar
• Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971–1972 and 1999–2004. Arch Ophthalmol. 2009;127(12):1632–1639. doi:10.1001/archophthalmol.2009.303
   PubMedGoogle Scholar
• Ojaimi E, Rose KA, Morgan IG, et al. Distribution of ocular biometric parameters and refraction in a population-based study of Australian children. Invest Ophthalmol Vis Sci. 2005;46(8):2748–2754. doi:10.1167/iovs.04-1324
   PubMed Web of Science ®Google Scholar
• O’Donoghue LS, McClelland KJ, Logan JF, Rudnicka NS, Owen AR. Prevalence of childhood refractive error in the United Kingdom. Invest Ophthalmol Vis Sci. 2009;50(13):2562.
   Google Scholar
• Wen G, Tarczy-Hornoch K, McKean-Cowdin R, et al. Prevalence of myopia, hyperopia, and astigmatism in non-Hispanic white and Asian children: multi-ethnic pediatric eye disease study. Ophthalmology. 2013;120(10):2109–2116. doi:10.1016/j.ophtha.2013.06.039
   PubMed Web of Science ®Google Scholar
• Multi-Ethnic Pediatric Eye Disease Study, G. Prevalence of myopia and hyperopia in 6- to 72-month-old african american and Hispanic children: the multi-ethnic pediatric eye disease study. Ophthalmology. 2010;117(1):140–147.e3. doi:10.1016/j.ophtha.2009.06.009
   Web of Science ®Google Scholar
• Kleinstein RN, Jones LA, Hullett S, et al. Refractive error and ethnicity in children. Arch Ophthalmol. 2003;121(8):1141–1147. doi:10.1001/archopht.121.8.1141
   PubMedGoogle Scholar
• Ying G-S, Maguire MG, Cyert LA, et al. Prevalence of vision disorders by racial and ethnic group among children participating in head start. Ophthalmology. 2014;121(3):630–636. doi:10.1016/j.ophtha.2013.09.036
   PubMed Web of Science ®Google Scholar
• Theophanous C, Modjtahedi B, Batech M, et al. Myopia prevalence and risk factors in children. Clin Ophthalmol. 2018;12:1581–1587. doi:10.2147/OPTH
   Web of Science ®Google Scholar
• O’Donoghue L, Kapetanankis VV, McClelland JF, et al. Risk factors for childhood myopia: findings from the NICER study. Invest Ophthalmol Vis Sci. 2015;56(3):1524–1530. doi:10.1167/iovs.14-15549
   Web of Science ®Google Scholar
• Ip JM, Huynh SC, Robaei D, et al. Ethnic differences in the impact of parental myopia: findings from a population-based study of 12-year-old Australian children. Invest Ophthalmol Vis Sci. 2007;48(6):2520–2528. doi:10.1167/iovs.06-0716
   Web of Science ®Google Scholar
• Zadnik K, Satariano WA, Mutti DO, et al. The effect of parental history of myopia on children’s eye size. JAMA. 1994;271(17):1323–1327. doi:10.1001/jama.1994.03510410035029
   PubMed Web of Science ®Google Scholar
• Lam DSC, Fan DSP, Lam RF, et al. The effect of parental history of myopia on children’s eye size and growth: results of a longitudinal study. Invest Ophthalmol Vis Sci. 2008;49(3):873–876. doi:10.1167/iovs.06-1097
   Web of Science ®Google Scholar
• Liang C-L, Yen E, Su J-Y, et al. Impact of family history of high myopia on level and onset of myopia. Invest Ophthalmol Vis Sci. 2004;45(10):3446–3452. doi:10.1167/iovs.03-1058
   PubMed Web of Science ®Google Scholar
• Ghorbani Mojarrad N, Williams C, Guggenheim JA. A genetic risk score and number of myopic parents independently predict myopia. Ophthalmic Physiol Optics. 2018;38(5):492–502. doi:10.1111/opo.2018.38.issue-5
   Web of Science ®Google Scholar
• Verhoeven VJM, Hysi PG, Wojciechowski R, et al. Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet. 2013;45(3):314–318. doi:10.1038/ng.2554
   PubMed Web of Science ®Google Scholar
• Hysi PG, Wojciechowski R, Rahi JS, et al. Genome-wide association studies of refractive error and myopia, lessons learned, and implications for the future. Investigative Opthalmology & Visual Science. 2014;55(5):3344–3351. doi:10.1167/iovs.14-14149
   PubMed Web of Science ®Google Scholar
• Kiefer AK, Tung JY, Do CB, et al. Genome-wide analysis points to roles for extracellular matrix remodeling, the visual cycle, and neuronal development in Myopia. PLoS Genet. 2013;9(2):e1003299. doi:10.1371/journal.pgen.1003299
   PubMed Web of Science ®Google Scholar
• Wong TY, Foster PJ, Johnson GJ, et al. Education, socioeconomic status, and ocular dimensions in Chinese adults: the Tanjong Pagar Survey. The British Journal of Ophthalmology. 2002;86(9):963–968. doi:10.1136/bjo.86.9.963
   Web of Science ®Google Scholar
• Mutti DO, Mitchell GL, Moeschberger ML, et al. Parental Myopia, near work, school achievement, and children’s refractive error. Invest Ophthalmol Vis Sci. 2002;43(12):3633–3640.
   PubMed Web of Science ®Google Scholar
• Mountjoy E, Davies NM, Plotnikov D, et al. Education and myopia: assessing the direction of causality by mendelian randomisation. BMJ. 2018;361:k2022–k2022. doi:10.1136/bmj.k2022
   PubMed Web of Science ®Google Scholar
• Williams KM, Bertelsen G, Cumberland P, et al. Increasing prevalence of Myopia in Europe and the impact of education. Ophthalmology. 2015;122(7):1489–1497. doi:10.1016/j.ophtha.2015.03.018
   PubMed Web of Science ®Google Scholar
• Saw S-M, Hong C-Y, Chia K-S, et al. Nearwork and myopia in young children. The Lancet. 2001;357(9253):390. doi:10.1016/S0140-6736(05)71520-8
   Web of Science ®Google Scholar
• Ip JM, Saw S-M, Rose KA, et al. Role of near work in Myopia: findings in a sample of Australian school children. Investigative Opthalmology & Visual Science. 2008;49(7):2903–2910. doi:10.1167/iovs.07-0804
   PubMed Web of Science ®Google Scholar
• Ramessur R, Williams KM, Hammond CJ. Risk factors for myopia in a discordant monozygotic twin study. Ophthalmic Physiol Opt. 2015;35(6):643–651. doi:10.1111/opo.12246
   PubMed Web of Science ®Google Scholar
• Jones LA, Sinnott LT, Mutti DO, et al. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007;48(8):3524–3532. doi:10.1167/iovs.06-1118
   PubMed Web of Science ®Google Scholar
• Rose KA, Morgan IG, Ip J, et al. Outdoor activity reduces the prevalence of myopia in children. Ophthalmology. 2008;115(8):1279–1285. doi:10.1016/j.ophtha.2007.12.019
   PubMed Web of Science ®Google Scholar
• Dirani M, Tong L, Gazzard G, et al. Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol. 2009;93(8):997–1000. doi:10.1136/bjo.2008.150979
   PubMed Web of Science ®Google Scholar
• Guggenheim JA, Northstone K, McMahon G, et al. Time outdoors and physical activity as predictors of incident myopia in childhood: a prospective cohort study. Invest Ophthalmol Vis Sci. 2012;53(6):2856–2865. doi:10.1167/iovs.11-9091
   PubMed Web of Science ®Google Scholar
• McCarthy CS, Megaw P, Devadas M, et al. Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia. Exp Eye Res. 2007;84(1):100–107. doi:10.1016/j.exer.2006.09.018
   Web of Science ®Google Scholar
• Raviola E, Wiesel TN. Effect of dark-rearing on experimental myopia in monkeys. Invest Ophthalmol Vis Sci. 1978;17(6):485–488.
   Web of Science ®Google Scholar
• Crewther DP. The role of photoreceptors in the control of refractive state. Prog Retin Eye Res. 2000;19(4):421–457. doi:10.1016/s1350-9462(00)00004-5
   Web of Science ®Google Scholar
• Fredrick DR. Myopia. BMJ. 2002;324(7347):1195–1199. doi:10.1136/bmj.324.7347.1195
   PubMed Web of Science ®Google Scholar
• Iuvone PM, Tigges M, Fernandes A, et al. Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation. Vis Neurosci. 1989;2(5):465–471. doi:10.1017/s0952523800012360
   Web of Science ®Google Scholar
• Stone RA, Lin T, Laties AM, et al. Retinal dopamine and form-deprivation myopia. Proc Natl Acad Sci U S A. 1989;86(2):704–706. doi:10.1073/pnas.86.2.704
   Web of Science ®Google Scholar
• Dong F, Zhi Z, Pan M, et al. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis. 2011;17:2824–2834.
   Web of Science ®Google Scholar
• Gao Q, Liu Q, Ma P, et al. Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1329–1335. doi:10.1007/s00417-006-0254-1
   Web of Science ®Google Scholar
• Junfeng M, Shuangzhen L, Wenjuan Q, et al. Levodopa inhibits the development of form-deprivation myopia in guinea pigs. Optom Vis Sci. 2010;87(1):53–60. doi:10.1097/OPX.0b013e3181c12b3d
   Web of Science ®Google Scholar
• Beaulieu J-M, Gainetdinov RR, Sibley DR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev. 2011;63(1):182–217. doi:10.1124/pr.110.002642
   PubMed Web of Science ®Google Scholar
• Schmid KL, Strasberg G, Rayner CL, et al. The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision. Exp Eye Res. 2013;110:88–95. doi:10.1016/j.exer.2013.02.017
   Web of Science ®Google Scholar
• Huang F, Yan T, Shi F, et al. Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse. Invest Ophthalmol Vis Sci. 2014;55(9):5537–5544. doi:10.1167/iovs.13-13211
   Web of Science ®Google Scholar
• Zhang S, Yang J, Reinach PS, et al. Dopamine receptor subtypes mediate opposing effects on form deprivation Myopia in pigmented guinea pigs. Invest Ophthalmol Vis Sci. 2018;59(11):4441–4448. doi:10.1167/iovs.17-21574
   PubMed Web of Science ®Google Scholar
• Stone RA, Laties AM, Raviola E, et al. Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates. Proc Natl Acad Sci U S A. 1988;85(1):257–260. doi:10.1073/pnas.85.1.257
   Web of Science ®Google Scholar
• Stone RA, Kuwayama Y, Laties AM. Regulatory peptides in the eye. Experientia. 1987;43(7):791–800. doi:10.1007/BF01945357
   Google Scholar
• Seltner RL, Stell WK. The effect of vasoactive intestinal peptide on development of form deprivation myopia in the chick: a pharmacological and immunocytochemical study. Vision Res. 1995;35(9):1265–1270. doi:10.1016/0042-6989(94)00244-G
   Web of Science ®Google Scholar
• Shih Y-F, Fitzgerald M, Cuthbertson SL, et al. Influence of ophthalmic nerve fibers on choroidal blood flow and myopic eye growth in chicks. Exp Eye Res. 1999;69(1):9–20. doi:10.1006/exer.1999.0692
   Web of Science ®Google Scholar
• Stone RA, Kuwayama Y. Substance P-like immunoreactive nerves in the human eye. Arch Ophthalmol. 1985;103(8):1207–1211. doi:10.1001/archopht.1985.01050080119031
   Google Scholar
• Corvetti G, Pignocchino P, Sisto Daneo L. Distribution and development of substance P immunoreactive axons in the chick cornea and uvea. Basic Appl Histochem. 1988;32(1):187–192.
   PubMedGoogle Scholar
• Denis P, Fardin V, Nordmann JP, et al. Localization and characterization of substance P binding sites in rat and rabbit eyes. Invest Ophthalmol Vis Sci. 1991;32(6):1894–1902.
   PubMed Web of Science ®Google Scholar
• Raecker ME, AK L. Diagnosis of CNV in Myopic Macular Degeneration. EyeNet; 2015:35–37.
   Google Scholar
• Yokoi T, Ohno-Matsui K. Diagnosis and Treatment of Myopic Maculopathy. RetinaToday; 2014:37–40.
   Google Scholar
• Saw S-M, Gazzard G, Shih-Yen EC, et al. Myopia and associated pathological complications. Ophthalmic Physiol Optics. 2005;25(5):381–391. doi:10.1111/j.1475-1313.2005.00298.x
   PubMed Web of Science ®Google Scholar
• Green WR, Wilson DJ. Choroidal neovascularization. Ophthalmology. 1986;93(9):1169–1176. doi:10.1016/S0161-6420(86)33609-1
   PubMed Web of Science ®Google Scholar
• Wong TY, et al. Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol. 2015;99(3):289–296.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology. 2003;110(7):1297–1305. doi:10.1016/S0161-6420(03)00461-5
   PubMed Web of Science ®Google Scholar
• Muller B, Joussen AM. Myopic traction maculopathy - vitreoretinal traction syndrome in high myopic eyes and posterior staphyloma. Klin Monbl Augenheilkd. 2011;228(9):771–779. doi:10.1055/s-0031-1281714
   Web of Science ®Google Scholar
• Takano M, Kishi S. Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol. 1999;128(4):472–476. doi:10.1016/S0002-9394(99)00186-5
   PubMed Web of Science ®Google Scholar
• Ikuno Y, Tano Y. Vitrectomy for macular holes associated with myopic foveoschisis. Am J Ophthalmol. 2006;141(4):774–776. doi:10.1016/j.ajo.2005.11.044
   PubMed Web of Science ®Google Scholar
• Bando H, Ikuno Y, Choi J-S, et al. Ultrastructure of internal limiting membrane in myopic foveoschisis. Am J Ophthalmol. 2005;139(1):197–199. doi:10.1016/j.ajo.2004.07.027
   PubMed Web of Science ®Google Scholar
• Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004;122(10):1455–1460. doi:10.1001/archopht.122.10.1455
   PubMedGoogle Scholar
• Benhamou N, Massin P, Haouchine B, et al. Macular retinoschisis in highly myopic eyes. Am J Ophthalmol. 2002;133(6):794–800. doi:10.1016/S0002-9394(02)01394-6
   PubMed Web of Science ®Google Scholar
• Gohil R, Sivaprasad S, Han LT, et al. Myopic foveoschisis: a clinical review. Eye (Lond). 2015;29(5):593–601. doi:10.1038/eye.2014.311
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kobayashi K, Okinami S. Macular hole and myopic refraction. Br J Ophthalmol. 2002;86(11):1269–1273. doi:10.1136/bjo.86.11.1269
   PubMed Web of Science ®Google Scholar
• Gwiazda J. Treatment options for myopia. Optometry Vision Sci. 2009;86(6):624–628. doi:10.1097/OPX.0b013e3181a6a225
   Web of Science ®Google Scholar
• Hung L-F, Crawford ML, Smith EL. Spectacle lenses alter eye growth and the refractive status of young monkeys. Nat Med. 1995;1(8):761–765. doi:10.1038/nm0895-761
   Web of Science ®Google Scholar
• Chung K, Mohidin N, O’Leary DJ. Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res. 2002;42(22):2555–2559. doi:10.1016/S0042-6989(02)00258-4
   PubMed Web of Science ®Google Scholar
• Adler D, Millodot M. The possible effect of undercorrection on myopic progression in children. Clin Exp Optom. 2006;89(5):315–321. doi:10.1111/cxo.2006.89.issue-5
   PubMed Web of Science ®Google Scholar
• Sankaridurg P, Donovan L, Varnas S, et al. Spectacle lenses designed to reduce progression of myopia: 12-month results. Optometry Vision Sci. 2010;87(9):631–641. doi:10.1097/OPX.0b013e3181ea19c7
   PubMed Web of Science ®Google Scholar
• Kanda H, Oshika T, Hiraoka T, et al. Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial. Jpn J Ophthalmol. 2018;62(5):537–543. doi:10.1007/s10384-018-0616-3
   Web of Science ®Google Scholar
• Gwiazda J, e A. Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest Ophthalmol Vis Sci. 2011;52(5):2749–2757.
   Web of Science ®Google Scholar
• Walline JJ, Mutti DO, Jones LA, et al. The contact lens and myopia progression (CLAMP) study: design and baseline data. Optom Vis Sci. 2001;78(4):223–233. doi:10.1097/00006324-200104000-00011
   Web of Science ®Google Scholar
• Grosvenor T, PERRIGIN D, PERRIGIN J, et al. Rigid gas-permeable contact lenses for myopia control: effects of discontinuation of lens wear. Optom Vis Sci. 1991;68(5):385–389. doi:10.1097/00006324-199105000-00011
   Web of Science ®Google Scholar
• Khoo CY, Chong J, Rajan U. A 3-year study on the effect of RGP contact lenses on myopic children. Singapore Med J. 1999;40(4):230–237.
   Google Scholar
• Katz J, Schein OD, Levy B, et al. A randomized trial of rigid gas permeable contact lenses to reduce progression of children’s myopia. Am J Ophthalmol. 2003;136(1):82–90. doi:10.1016/S0002-9394(03)00106-5
   Web of Science ®Google Scholar
• Walline JJ, Greiner KL, McVey ME, et al. Multifocal contact lens myopia control. Optom Vis Sci. 2013;90(11):1207–1214. doi:10.1097/OPX.0000000000000036
   PubMed Web of Science ®Google Scholar
• Anstice NS, Phillips JR. Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology. 2011;118(6):1152–1161. doi:10.1016/j.ophtha.2010.10.035
   PubMed Web of Science ®Google Scholar
• Beasley IG, Davies LN, Logan NS. Effect of peripheral defocus on axial eye growth and modulation of refractive error in hyperopes: protocol for a nonrandomized clinical trial. JMIR Res Protoc. 2018;7(9):e173–e173. doi:10.2196/resprot.9320
   Web of Science ®Google Scholar
• Lam CSY, Tang WC, Tse DY-Y, et al. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br J Ophthalmol. 2014;98(1):40–45. doi:10.1136/bjophthalmol-2013-303914
   PubMed Web of Science ®Google Scholar
• Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2019;bjophthalmol-2018-313739.
   Web of Science ®Google Scholar
• Lu Y, Lin Z, Wen L, et al. The adaptation and acceptance of defocus incorporated multiple segment lens for Chinese children. Am J Ophthalmol. 2019. doi:10.1016/j.ajo.2019.12.002
   Web of Science ®Google Scholar
• Ruiz-Pomeda A, Pérez-Sánchez B, Valls I, et al. MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2018;256(5):1011–1021. doi:10.1007/s00417-018-3906-z
   PubMed Web of Science ®Google Scholar
• Chamberlain P, Peixoto-de-Matos SC, Logan NS, et al. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96(8):556–567. doi:10.1097/OPX.0000000000001410
   PubMed Web of Science ®Google Scholar
• Saw SM, Gazzard G, Au Eong K-G, et al. Myopia: attempts to arrest progression. Br J Ophthalmol. 2002;86(11):1306–1311. doi:10.1136/bjo.86.11.1306
   PubMed Web of Science ®Google Scholar
• Polse KA, BRAND RJ, SCHWALBE JS, et al. The Berkeley Orthokeratology Study, Part II: efficacy and duration. Am J Optom Physiol Opt. 1983;60(3):187–198. doi:10.1097/00006324-198303000-00006
   PubMedGoogle Scholar
• Leo S-W, Young TL. An evidence-based update on myopia and interventions to retard its progression. J AAPOS. 2011;15(2):181–189. doi:10.1016/j.jaapos.2010.09.020
   PubMed Web of Science ®Google Scholar
• Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005;30(1):71–80. doi:10.1080/02713680590907256
   PubMed Web of Science ®Google Scholar
• Liu YM, Xie P. The safety of orthokeratology–a systematic review. Eye Contact Lens. 2016;42(1):35–42. doi:10.1097/ICL.0000000000000219
   PubMed Web of Science ®Google Scholar
• Kam KW, Yung W, Li GKH, et al. Infectious keratitis and orthokeratology lens use: a systematic review. Infection. 2017;45(6):727–735. doi:10.1007/s15010-017-1023-2
   Web of Science ®Google Scholar
• Barathi VA, Weon SR, Beuerman RW. Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation. Mol Vis. 2009;15:1277–1293.
   PubMed Web of Science ®Google Scholar
• Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680–692.
   Web of Science ®Google Scholar
• Lee C-Y, Sun -C-C, Lin Y-F, et al. Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study. BMC Ophthalmol. 2016;16:114. doi:10.1186/s12886-016-0297-y
   PubMed Web of Science ®Google Scholar
• Chua W-H, Balakrishnan V, Chan Y-H, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113(12):2285–2291. doi:10.1016/j.ophtha.2006.05.062
   PubMed Web of Science ®Google Scholar
• Chia A, Chua W-H, Cheung Y-B, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119(2):347–354. doi:10.1016/j.ophtha.2011.07.031
   PubMed Web of Science ®Google Scholar
• Chia A, Lu Q-S, Tan D. Five-year clinical trial on atropine for the treatment of Myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391–399. doi:10.1016/j.ophtha.2015.07.004
   PubMed Web of Science ®Google Scholar
• Shih Y-F, Hsiao CK, Chen C-J, et al. An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression. Acta Ophthalmol Scand. 2001;79(3):233–236. doi:10.1034/j.1600-0420.2001.790304.x
   PubMedGoogle Scholar
• Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in Myopia control. Ophthalmology. 2019;126(1):113–124. doi:10.1016/j.ophtha.2018.05.029
   PubMed Web of Science ®Google Scholar
• Siatkowski RM, et al. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study. Arch Ophthalmol. 2004;122(11):1667–1674. doi:10.1001/archopht.122.11.1667
   Google Scholar
• Truong H-T, Cottriall CL, Gentle A, et al. Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. Exp Eye Res. 2002;74(1):103–111. doi:10.1006/exer.2001.1107
   PubMed Web of Science ®Google Scholar
• Xu Z-W, Chen X, Jin X-H, et al. SILAC-based proteomic analysis reveals that salidroside antagonizes cobalt chloride-induced hypoxic effects by restoring the tricarboxylic acid cycle in cardiomyocytes. J Proteomics. 2016;130:211–220. doi:10.1016/j.jprot.2015.09.028
   Web of Science ®Google Scholar
• Wu J, Ke X, Ma N, et al. Formononetin, an active compound of Astragalus membranaceus (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1α/VEGF signaling pathway. Drug Des Devel Ther. 2016;10:3071–3081. doi:10.2147/DDDT
   PubMed Web of Science ®Google Scholar
• Lai M-C, Lin J-G, Pai P-Y, et al. Protective effect of salidroside on cardiac apoptosis in mice with chronic intermittent hypoxia. Int J Cardiol. 2014;174(3):565–573. doi:10.1016/j.ijcard.2014.04.132
   Web of Science ®Google Scholar
• Huang X, Zou L, Yu X, et al. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway. J Mol Cell Cardiol. 2015;82:153–166. doi:10.1016/j.yjmcc.2015.03.005
   PubMed Web of Science ®Google Scholar
• Bishopric NH, Andreka, P., Slepak, T., & Webster, K. A, et al. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol. 2001;1(2):141–150. doi:10.1016/S1471-4892(01)00032-7
   PubMedGoogle Scholar
• Zhong X, Lin R, Li Z, et al. Effects of Salidroside on cobalt chloride-induced hypoxia damage and mTOR signaling repression in PC12 cells. Biol Pharm Bull. 2014;37(7):1199–1206. doi:10.1248/bpb.b14-00100
   PubMed Web of Science ®Google Scholar
• Sun M, Zhou T, Zhou L, et al. Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sAbetaPPalpha. J Alzheimers Dis. 2012;28(4):795–808. doi:10.3233/JAD-2011-110506
   Web of Science ®Google Scholar
• Shevelev M. Operation against high myopia and scleralectasia with aid of the transplantation of fascia lata on thinned sclera. Russ Oftalmol J. 1930;11:107–110.
   Google Scholar
• Thompson FB. A simplified scleral reinforcement technique. Am J Ophthalmol. 1978;86(6):782–790. doi:10.1016/0002-9394(78)90121-6
   Web of Science ®Google Scholar
• Shen Z-M, Zhang Z-Y, Zhang L-Y, et al. Posterior scleral reinforcement combined with patching therapy for pre-school children with unilateral high myopia. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1391–1395. doi:10.1007/s00417-015-2963-9
   PubMed Web of Science ®Google Scholar
• Li X-J, Yang X-P, Li Q-M, et al. Posterior scleral reinforcement for the treatment of pathological myopia. Int J Ophthalmol. 2016;9(4):580–584. doi:10.18240/ijo.2016.04.18
   Web of Science ®Google Scholar
• Liu XD, Lu JH, Chu RY. Long-term studies on clinical therapeutic efficiency of posterior scleral reinforcement surgery. Zhonghua Yan Ke Za Zhi. 2011;47(6):527–530.
   Google Scholar
• Parolini B, Frisina R, Pinackatt S, et al. Indications and results of a new L-shaped macular buckle to support a posterior staphyloma in high Myopia. Retina. 2015;35(12):2469–2482. doi:10.1097/IAE.0000000000000613
   Web of Science ®Google Scholar
• Devin F, Tsui I, Morin B, et al. T-shaped scleral buckle for macular detachments in high myopes. Retina. 2011;31(1):177–180. doi:10.1097/IAE.0b013e3181fc7e73
   Web of Science ®Google Scholar
• Stirpe M, Ripandelli G, Rossi T, et al. A new adjustable macular buckle designed for highly Myopic eyes. Retina (Philadelphia, PA). 2012;32(7):1424–1427. doi:10.1097/IAE.0b013e3182550648
   PubMed Web of Science ®Google Scholar
• Theodossiadis GP, Theodossiadis PG. The macular buckling procedure in the treatment of retinal detachment in highly myopic eyes with macular hole and posterior staphyloma: mean follow-up of 15 years. Retina. 2005;25(3):285–289. doi:10.1097/00006982-200504000-00006
   Web of Science ®Google Scholar
• Sasoh M, Yoshida S, Ito Y, et al. Macular buckling for retinal detachment due to macular hole in highly myopic eyes with posterior staphyloma. Retina. 2000;20(5):445–449. doi:10.1097/00006982-200005000-00003
   Web of Science ®Google Scholar
• Vagge A, Ferro Desideri L, Nucci P, Serafino M. Prevention of progression in Myopia: a systematic review. Diseases. 2018;6(4).
   Google Scholar
• Sankaridurg P, et al. Controlling progression of Myopia: optical and pharmaceutical strategies. Asia Pac J Ophthalmol (Phila). 2018.
   Web of Science ®Google Scholar
• Young TL, Ronan SM, Alvear AB, et al. A second locus for familial high myopia maps to chromosome 12q. The American Journal of Human Genetics. 1998;63(5):1419–1424. doi:10.1086/302111
   Web of Science ®Google Scholar
• Young TL, Atwood LD, Ronan SM, et al. Further refinement of the MYP2 locus for autosomal dominant high myopia by linkage disequilibrium analysis. Ophthalmic Genet. 2001;22(2):69–75. doi:10.1076/opge.22.2.69.2233
   PubMedGoogle Scholar
• Scavello GS, Paluru PC, Ganter WR, et al. Sequence variants in the Transforming Growth β-Induced Factor (TGIF) gene are not associated with high Myopia. Invest Ophthalmol Vis Sci. 2004;45(7):2091–2097. doi:10.1167/iovs.03-0933
   Web of Science ®Google Scholar
• Paluru P, Ronan SM, Heon E, et al. New locus for autosomal dominant high myopia maps to the long arm of chromosome 17. Invest Ophthalmol Vis Sci. 2003;44(5):1830–1836. doi:10.1167/iovs.02-0697
   PubMed Web of Science ®Google Scholar
• Hammond CJ, Andrew T, Tat Mak Y, et al. A susceptibility locus for myopia in the normal population is linked to the PAX6 gene region on chromosome 11: a genomewide scan of dizygotic twins. The American Journal of Human Genetics. 2004;75(2):294–304. doi:10.1086/423148
   PubMed Web of Science ®Google Scholar
• Stambolian D, Ibay G, Reider L, et al. Genomewide linkage scan for myopia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 22q12. Am J Hum Genet. 2004;75(3):448–459. doi:10.1086/423789
   Web of Science ®Google Scholar
• Zhang Q, Guo X, Xiao X, et al. A new locus for autosomal dominant high myopia maps to 4q22-q27 between D4S1578 and D4S1612. Mol Vis. 2005;11:554–560.
   PubMed Web of Science ®Google Scholar
• Paluru PC, Nallasamy S, Devoto M, et al. Identification of a novel locus on 2q for autosomal dominant high-grade Myopia. Investigative Opthalmology & Visual Science. 2005;46(7):2300–2307. doi:10.1167/iovs.04-1423
   Web of Science ®Google Scholar
• Wojciechowski R, Moy C, Ciner E, et al. Genomewide scan in Ashkenazi Jewish families demonstrates evidence of linkage of ocular refraction to a QTL on chromosome 1p36. Hum Genet. 2006;119(4):389–399. doi:10.1007/s00439-006-0153-x
   Web of Science ®Google Scholar
• Zhang Q, et al. Novel locus for X linked recessive high myopia maps to Xq23-q25 but outside MYP1. J Med Genet. 2006;43(5):e20. doi:10.1136/jmg.2005.037853
   Web of Science ®Google Scholar
• Nallasamy S, Paluru PC, Devoto M, et al. Genetic linkage study of high-grade myopia in a Hutterite population from South Dakota. Mol Vis. 2007;13:229–236.
   PubMed Web of Science ®Google Scholar
• Ciner E, Wojciechowski R, Ibay G, et al. Genomewide scan of ocular refraction in African-American families shows significant linkage to chromosome 7p15. Genet Epidemiol. 2008;32(5):454–463. doi:10.1002/gepi.v32:5
   Web of Science ®Google Scholar
• Paget S, Julia S, Vitezica ZG, et al. Linkage analysis of high myopia susceptibility locus in 26 families. Mol Vis. 2008;14:2566–2574.
   PubMed Web of Science ®Google Scholar
• Lam CY, Tam POS, Fan DSP, et al. A genome-wide scan maps a novel high myopia locus to 5p15. Invest Ophthalmol Vis Sci. 2008;49(9):3768–3778. doi:10.1167/iovs.07-1126
   Web of Science ®Google Scholar
• Ciner E, Ibay G, Wojciechowski R, et al. Genome-wide scan of African-American and white families for linkage to myopia. Am J Ophthalmol. 2009;147(3):512–517.e2. doi:10.1016/j.ajo.2008.09.004
   Web of Science ®Google Scholar
• Yang Z, Xiao X, Li S, et al. Clinical and linkage study on a consanguineous Chinese family with autosomal recessive high myopia. Mol Vis. 2009;15:312–318.
   PubMed Web of Science ®Google Scholar
• Hysi PG, Young TL, Mackey DA, et al. A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25. Nat Genet. 2010;42(10):902–905. doi:10.1038/ng.664
   PubMed Web of Science ®Google Scholar
• Solouki AM, Verhoeven VJM, van Duijn CM, et al. A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14. Nat Genet. 2010;42(10):897–901. doi:10.1038/ng.663
   PubMed Web of Science ®Google Scholar
• Ma J-H, Shen S-H, Zhang G-W, et al. Identification of a locus for autosomal dominant high myopia on chromosome 5p13.3-p15.1 in a Chinese family. Mol Vis. 2010;16:2043–2054.
   PubMed Web of Science ®Google Scholar
• Guo X, Xiao X, Li S, et al. Nonsyndromic high myopia in a Chinese family mapped to MYP1: linkage confirmation and phenotypic characterization. Arch Ophthalmol. 2010;128(11):1473–1479. doi:10.1001/archophthalmol.2010.270
   Google Scholar
• Rydzanicz M, Nath SK, Sun C, et al. Identification of novel suggestive loci for high-grade myopia in Polish families. Mol Vis. 2011;17:2028–2039.
   PubMed Web of Science ®Google Scholar
• Han S, Chen P, Fan Q, et al. Association of variants in FRAP1 and PDGFRA with corneal curvature in Asian populations from Singapore. Hum Mol Genet. 2011;20(18):3693–3698. doi:10.1093/hmg/ddr269
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhou J, Chen X, et al. Polymorphisms in the CTNND2 gene and 11q24.1 genomic region are associated with pathological myopia in a Chinese population. Ophthalmologica. 2012;228(2):123–129. doi:10.1159/000338188
   Web of Science ®Google Scholar
• Abbott D, Li Y-J, Guggenheim JA, et al. An international collaborative family-based whole genome quantitative trait linkage scan for myopic refractive error. Mol Vis. 2012;18:720–729.
   PubMed Web of Science ®Google Scholar
• Fan Q, Barathi VA, Cheng C-Y, et al. Genetic variants on chromosome 1q41 influence ocular axial length and high myopia. PLoS Genet. 2012;8(6):e1002753–e1002753. doi:10.1371/journal.pgen.1002753
   PubMed Web of Science ®Google Scholar
• Mishra A, Yazar S, Hewitt AW, et al. Genetic variants near PDGFRA are associated with corneal curvature in Australians. Investigative Opthalmology & Visual Science. 2012;53(11):7131–7136. doi:10.1167/iovs.12-10489
   PubMed Web of Science ®Google Scholar
• Cheng C-Y, Schache M, Ikram M, et al. Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error. Am J Hum Genet. 2013;93(2):264–277. doi:10.1016/j.ajhg.2013.06.016
   PubMed Web of Science ®Google Scholar
• Guggenheim JA, McMahon G, Kemp JP, et al. A genome-wide association study for corneal curvature identifies the platelet-derived growth factor receptor α gene as a quantitative trait locus for eye size in white Europeans. Mol Vis. 2013;19:243–253.
   PubMed Web of Science ®Google Scholar
• Wang H, Yang M, Su S, et al. Association of ZNF644, GRM6 and CTNND2 genes polymorphisms with high myopia. Zhonghua Yi Xue Za Zhi. 2014;94(17):1289–1293.
   Google Scholar
• Chen T, Shan G, Ma J, et al. Polymorphism in the RASGRF1 gene with high myopia: a meta-analysis. Mol Vis. 2015;21:1272–1280.
   PubMed Web of Science ®Google Scholar
• Wang H, Su S, Yang M, et al. Association of ZNF644, GRM6, and CTNND2 genes with high myopia in the Han Chinese population: Jiangsu Eye Study. Eye (Lond). 2016;30(7):1017–1022. doi:10.1038/eye.2016.8
   Web of Science ®Google Scholar
• Liao X, Yap MKH, Leung KH, et al. Genetic association study of KCNQ5 polymorphisms with high Myopia. Biomed Res Int. 2017;2017:3024156. doi:10.1155/2017/3024156
   Web of Science ®Google Scholar
• Musolf AM, Simpson CL, Moiz BA, et al. Caucasian families exhibit significant linkage of Myopia to chromosome 11p. Investigative Opthalmology & Visual Science. 2017;58(9):3547–3554. doi:10.1167/iovs.16-21271
   Web of Science ®Google Scholar
• Musolf AM, Simpson CL, Long KA, et al. Myopia in Chinese families shows linkage to 10q26.13. Mol Vis. 2018;24:29–42.
   Web of Science ®Google Scholar
• Wojciechowski R, Stambolian D, Ciner E, et al. Genomewide linkage scans for ocular refraction and meta-analysis of four populations in the Myopia family study. Investigative Opthalmology & Visual Science. 2009;50(5):2024–2032. doi:10.1167/iovs.08-2848
   Web of Science ®Google Scholar
• Brodstein RS, Brodstein DE, Olson RJ, et al. The treatment of myopia with atropine and bifocals. A long-term prospective study. Ophthalmology. 1984;91(11):1373–1378. doi:10.1016/S0161-6420(84)34138-0
   PubMed Web of Science ®Google Scholar
• Yen MY, Liu JH, Kao SC, et al. Comparison of the effect of atropine and cyclopentolate on myopia. Ann Ophthalmol. 1989;21(5):180–2, 187.
   PubMedGoogle Scholar
• Chou A-C, SHIH Y-F, HO T-C, et al. The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther. 1997;13(1):61–67. doi:10.1089/jop.1997.13.61
   Web of Science ®Google Scholar
• Shih Y-F, CHEN C-H, CHOU A-C, et al. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999;15(1):85–90. doi:10.1089/jop.1999.15.85
   PubMed Web of Science ®Google Scholar
• Kennedy RH, Dyer JA, Kennedy MA, et al. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students. Binocul Vis Strabismus Q. 2000;15(3 Suppl):281–304.
   Google Scholar
• Hsiao CK, Chen CJ, Shih YF, et al. Design and statistical analysis for the Myopia intervention trial in Taiwan. In: Myopia Updates II. Tokyo: Springer Japan; 2000:161-164..
   Google Scholar
• Lee J-J, Fang P-C, Yang I-H, et al. Prevention of myopia progression with 0.05% atropine solution. J Ocul Pharmacol Ther. 2006;22(1):41–46. doi:10.1089/jop.2006.22.41
   PubMed Web of Science ®Google Scholar
• Fan DSP, Lam DSC, Chan CKM, et al. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study. Jpn J Ophthalmol. 2007;51(1):27–33. doi:10.1007/s10384-006-0380-7
   PubMed Web of Science ®Google Scholar
• Liang C-K, Ho T-Y, Li T-C, et al. A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial. Complement Ther Med. 2008;16(6):305–310. doi:10.1016/j.ctim.2008.04.007
   Web of Science ®Google Scholar
• Fang P-C, Chung M-Y, Yu H-J, et al. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010;26(4):341–345. doi:10.1089/jop.2009.0135
   PubMed Web of Science ®Google Scholar
• Wu PC, Yang YH, Fang PC. The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren. J Ocul Pharmacol Ther. 2011;27(5):461–466. doi:10.1089/jop.2011.0027
   PubMed Web of Science ®Google Scholar
• Lin L, Weizhong L, Yunru L, et al. Treatment outcomes of myopic anisometropia with 1% atropine: a pilot study. Optom Vis Sci. 2013;90(12):1486–1492. doi:10.1097/OPX.0000000000000097
   PubMed Web of Science ®Google Scholar
• Chia A, Li W, Tan D, et al. Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study. Doc Ophthalmol. 2013;126(3):177–186. doi:10.1007/s10633-012-9372-8
   PubMed Web of Science ®Google Scholar
• Cooper J, Eisenberg N, Schulman E, et al. Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci. 2013;90(12):1467–1472. doi:10.1097/OPX.0000000000000037
   PubMed Web of Science ®Google Scholar
• Lin H-J, Wan L, Tsai F-J, et al. Overnight orthokeratology is comparable with atropine in controlling myopia. BMC Ophthalmol. 2014;14(1):40. doi:10.1186/1471-2415-14-40
   Web of Science ®Google Scholar
• Cheng HC, Hsieh YT. The effect of low-concentration atropine combined with auricular acupoint stimulation in myopia control. Complement Ther Med. 2014;22(3):449–455. doi:10.1016/j.ctim.2014.03.004
   Web of Science ®Google Scholar
• Li S-M, Wu -S-S, Kang M-T, et al. Atropine slows myopia progression more in Asian than white children by meta-analysis. Optom Vis Sci. 2014;91(3):342–350. doi:10.1097/OPX.0000000000000178
   PubMed Web of Science ®Google Scholar
• Chia A, Chua W-H, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157(2):451–457.e1. doi:10.1016/j.ajo.2013.09.020
   PubMed Web of Science ®Google Scholar
• Kumaran A, Htoon HM, Tan D, et al. Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes. Invest Ophthalmol Vis Sci. 2015;56(9):5650–5655. doi:10.1167/iovs.14-14716
   Web of Science ®Google Scholar
• Yi S, Huang Y, Yu S-Z, et al. Therapeutic effect of atropine 1% in children with low myopia. J AAPOS. 2015;19(5):426–429. doi:10.1016/j.jaapos.2015.04.006
   PubMed Web of Science ®Google Scholar
• Clark TY, Clark RA. Atropine 0.01% eyedrops significantly reduce the progression of childhood Myopia. J Ocul Pharmacol Ther. 2015;31(9):541–545. doi:10.1089/jop.2015.0043
   PubMed Web of Science ®Google Scholar
• Polling JR, Kok RGW, Tideman JWL, et al. Effectiveness study of atropine for progressive myopia in Europeans. Eye (Lond). 2016;30(7):998–1004. doi:10.1038/eye.2016.78
   PubMed Web of Science ®Google Scholar
• Loughman J, Flitcroft D. The acceptability and visual impact of 0.01% atropine in a Caucasian population. The British Journal of ophthalmology. 2016;100(11):1525–1529. doi:10.1136/bjophthalmol-2015-307861
   Google Scholar
• Kothari M, Rathod V. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes. Indian J Ophthalmol. 2017;65(11):1178–1181. doi:10.4103/ijo.IJO_418_17
   PubMed Web of Science ®Google Scholar
• Wan L, et al. The synergistic effects of orthokeratology and atropine in slowing the progression of Myopia. J Clin Med. 2018;7(9):259.
   Web of Science ®Google Scholar